HKG  Suite C, Level 7, World Trust Tower, 50 Stanley Street, Central, Hong Kong +7 777 245 19 24 info@sparkling-labs.com
Request a quote

Home  /  Company

Sparkling Labs Limited

One entity, one owner,
one operating account.

A Hong Kong private limited company formed in 2026 to distribute industrial and medical equipment. Everything below is on the record and available in supporting documentation on request.

Overview

A distributor,
and nothing else.

Sparkling Labs Limited procures equipment and materials directly from OEM manufacturers and resells them to end-clients under its own commercial terms. Distribution is the whole of the business. There is no project execution to subcontract and no onward assignment of clients to third parties.

Two lines run in parallel. Industrial equipment — precision metalworking tooling, electrotechnical equipment, measuring instruments, machine-tool spare parts and consumables — is the core. Medical equipment — hydrocephalus management, neuromonitoring and external drainage — is a specialised second line supplied to licensed distributors.

The company holds no funds on behalf of third parties and performs no third-party payment processing. Every payment in and out relates to its own trading activity. As a company formed in 2026, operations currently centre on the two lines above; further service lines and counterparties will be added as the business scales.

Registry
Legal name
SPARKLING LABS LIMITED
Business Registration No.
80119053
Also the company number on the certificate of incorporation, and the tax identification number — one identifier under Hong Kong's UBI system
Jurisdiction
Hong Kong SAR
Business type
Private limited company
Year founded
2026
Industry
Industrial & medical equipment distribution
Registered office
Suite C, Level 7, World Trust Tower,
50 Stanley Street, Central, Hong Kong
Operating regions
Asia-Pacific (APAC) and the United Arab Emirates
Beneficial owner
Sklyomin Alexey — 100%, held directly

Geographic footprint

Three directions,
three currencies.

Sales — outbound

Asia-Pacific and the United Arab Emirates

Key markets across APAC and the UAE. B2B only: industrial distributors and VARs, machine-tool service providers, and licensed medical-device distributors.

Receipts in USD by international wire

Procurement — industrial

Mainland China (PRC)

Direct purchasing of tooling and industrial equipment from OEM manufacturers, against verified trade invoices, to pre-approved accounts.

Payments in CNY by international wire

Procurement — medical

France

Neurosurgical and neuro-critical-care devices procured directly from the manufacturer, on the same basis.

Payments in EUR by international wire

Why Hong Kong

An ideal trading hub
— for unglamorous reasons.

Hong Kong sits directly alongside our Chinese procurement base and on the global delivery routes our clients ship along. That is what lets us buy from the manufacturer rather than from a broker, and quote a four-week cycle honestly.

The territory offers efficient customs procedures, a strong legal framework, and established banking infrastructure for cross-border settlement — which matters when money comes in as USD and goes out as CNY and EUR against the same order.

Trading model
Model
Principal trading — buy on own account, resell on own terms
Margin
Quoted per order on the value of goods
Subcontracting
None. We do not subcontract execution
Client assignment
None. Clients are not transferred or onward-assigned
Third-party funds
None held. No third-party payment processing
Channel
B2B only. No retail or consumer activity

Ownership structure

One name
on the register.

A single ultimate beneficial owner holds 100% of the shares directly. There are no nominee arrangements, no trust structures and no intermediate holding entities between the owner and the company.

Full supporting documentation is available on request.

Ultimate beneficial owner
Name
Sklyomin Alexey
Ownership
100%
Nationality
Kazakhstan
Role
Sole Director & Ultimate Beneficial Owner
Other shareholders
None
Holding structure
Direct ownership — no intermediate holding companies

The plan

USD 10M cumulative, by the close of 2027.

Targets set at incorporation — not results. Growth comes from onboarding industrial distributors and service providers, activating the medical channel, entering the UAE, and turning one-off orders into standing procurement relationships. Figures are cumulative revenue, not gross margin.

Cumulative revenue · USD · targets

Q1 2026

0.2M

Formation and first onboarding

Q2 2026

0.7M

First industrial distributor orders

Q3 2026

1.5M

Recurring orders, supplier framework

Q4 2026

2.7M

Medical channel activated

Q1 2027

4.2M

UAE market entry

Q2 2027

5.9M

Expanded order volume

Q3 2027

7.8M

Broader APAC coverage

Q4 2027

10.0M

Cumulative target reached

Next step

Want the documents?

Corporate documentation, counterparty details and trade paperwork are available to counterparties and reviewers on request.